85TiP Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients.

Saved in:
Bibliographic Details
Title: 85TiP Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients.
Authors: Keyaerts, M1 (AUTHOR), Xavier, C2 (AUTHOR), Everaert, H1 (AUTHOR), Vaneycken, I1 (AUTHOR), Fontaine, C3 (AUTHOR), Decoster, L4 (AUTHOR), Vanhoeij, M5 (AUTHOR), Caveliers, V1 (AUTHOR), Lahoutte, T1 (AUTHOR)
Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdz095.081